Physical Fatigue clinical trials

Explore recruiting physical fatigue clinical trials.

Recruiting physical fatigue studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Physical Fatigue trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase III, randomised, double-blind, placebo-controlled, parallel-group, pivotal trial to assess the efficacy and safety of sonlicromanol in adult subjects with a genetically confirmed mitochondrial DNA tRNALeu(UUR) m.3243A>G variant.

Italy, Germany, France, Netherlands, Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

EORTC-2238-GUCG: Intermittent Androgen deprivation Therapy in the era of AR pathway inhibitors; a phase 3 pragmatic randomized trial (DE-ESCALATE)

Belgium, Ireland, Croatia, Spain, France, Denmark +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Randomized, placebo-controlled, double-blind study to evaluate the efficacy of 2LEBV® and 2LXFS® on asthenia in patients with an EBV infection

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

BEAT Fatigue – Benefit of Elevated Administration of Thiamine for Fatigue in Rheumatoid Arthritis: A randomized, double-blind, placebo-controlled trial

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Study with an Open-Label Extension to Evaluate the Efficacy and Safety of Oral Rilzabrutinib (PRN1008) in Adults and Adolescents with Persistent or Chronic Immune Thrombocytopenia (ITP).

Hungary, Spain, Italy, Poland, Norway, France +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Physical Fatigue trials by city

Physical Fatigue in Toronto Physical Fatigue in Vancouver Physical Fatigue in Montreal Physical Fatigue in Calgary Physical Fatigue in Edmonton Physical Fatigue in Ottawa Physical Fatigue in Winnipeg Physical Fatigue in Quebec City Physical Fatigue in Hamilton Physical Fatigue in Kitchener Physical Fatigue in London Physical Fatigue in Halifax Physical Fatigue in New York Physical Fatigue in Los Angeles Physical Fatigue in Chicago Physical Fatigue in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease